Proton therapy for paediatric medulloblastoma
- PMID: 26830376
- PMCID: PMC6207934
- DOI: 10.1016/S1470-2045(15)00217-X
Proton therapy for paediatric medulloblastoma
Conflict of interest statement
The author declared no conflicts of interest.
Comment on
-
Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.Lancet Oncol. 2016 Mar;17(3):287-298. doi: 10.1016/S1470-2045(15)00167-9. Epub 2016 Jan 30. Lancet Oncol. 2016. PMID: 26830377 Clinical Trial.
References
-
- Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicenter trial. Lancet Oncol. 2006;7:813–20. - PubMed
-
- Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–08. - PubMed
-
- Thompson MC, Fuller C, Hogg TL, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol. 2006;24:1924–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
